A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
Clinical trial NCT05100199 · COMPLETED
Trial details
- NCT number
- NCT05100199
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2022-12-02
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.